FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients. ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models. Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumors
(Texas A&M University) Researchers at Texas A&M University are pushing organ-on-a-chip devices to new levels that could change the way clinicians approach cancer treatment, particularly ovarian cancer. A team has recently submitted a patent disclosure with the Texas A&M Engineering Experiment Station. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2021 Category: Cancer & Oncology Source Type: news

Johnson & Johnson Weighs Options for Talc Liabilities
Johnson & Johnson is considering the creation of a new subsidiary to absorb its widespread asbestos liabilities, according to reports in The Wall Street Journal and other news outlets. The J&J subsidiary would then declare Chapter 11 bankruptcy, potentially saving the multinational corporation billions of dollars. Reuters News Service also reported the subsidiary possibility, citing unnamed personal injury attorneys who learned of the option while negotiating their current claims with J&J officials. A spokesperson for Johnson & Johnson would not confirm the reports.  “Johnson & J...
Source: Asbestos and Mesothelioma News - July 22, 2021 Category: Environmental Health Authors: Chris Elkins Source Type: news

Ovarian cysts symptoms: Are ovarian cysts always cancerous?
OVARIAN cysts are fluid-filled sacs that develop on an ovary and don't normally cause any symptoms. So how do you know if you've got one, and are ovarian cysts always cancerous? (Source: Daily Express - Health)
Source: Daily Express - Health - July 21, 2021 Category: Consumer Health News Source Type: news

ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer
Dr Maurie Markman describes two large phase 3 trials that'clearly establish'the existing standard of care for cervical and ovarian cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 10, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Types of Ovarian Cancer Medications
Title: Types of Ovarian Cancer MedicationsCategory: Diseases and ConditionsCreated: 7/9/2021 12:00:00 AMLast Editorial Review: 7/9/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 9, 2021 Category: Cancer & Oncology Source Type: news

Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 7, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
WEDNESDAY, July 7, 2021 -- Oral contraceptive use is associated with a reduced risk for ovarian cancer for BRCA mutation carriers, according to a study published in the July issue of the American Journal of Obstetrics& Gynecology. Lieske H.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2021 Category: Pharmaceuticals Source Type: news

Ovarian Stimulation Drugs Not Tied to Higher Breast Cancer Risk
THURSDAY, July 1, 2021 -- Women treated with ovarian stimulation drugs for infertility do not have a significantly increased risk of breast cancer, according to a systematic review and meta-analysis published in the July issue of Fertility and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2021 Category: Pharmaceuticals Source Type: news

World-first artificial intelligence study to map risks of ovarian cancer in women
(University of South Australia) The University of South Australia will lead a world-first study, using artificial intelligence, to map the risks of the most fatal reproductive cancer in women worldwide so it can be detected and treated earlier. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news

Ovarian Cancer Management: We Have Come So Far Ovarian Cancer Management: We Have Come So Far
Gynecologic oncologist Dr Shannon Westin considers how far ovarian cancer management has come since she was in medical school, and speaks to the areas that still need to be addressed.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 29, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health MDAngle Source Type: news

GPS Vaccine Plus Opdivo Shows Promise for Pleural Mesothelioma
A novel, targeted cancer vaccine combined with the immunotherapy drug Opdivo has shown surprising efficacy for mesothelioma patients whose disease no longer responds to standard chemotherapy. In a phase I clinical trial at Memorial Sloan Kettering Cancer Center, the galinpepimut-S vaccine, also known as GPS, has produced an impressive, anti-tumor synergy with Opdivo, based upon early data. GPS targets the WT1 protein, which is expressed in high levels of various cancers but rarely seen in normal adult cells. The protein has been especially resistant to standard chemotherapy. The vaccine works by inducing a powerfu...
Source: Asbestos and Mesothelioma News - June 29, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

What Are the Early Warning Signs of Ovarian Cancer?
Title: What Are the Early Warning Signs of Ovarian Cancer?Category: Diseases and ConditionsCreated: 6/29/2021 12:00:00 AMLast Editorial Review: 6/29/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 29, 2021 Category: Cancer & Oncology Source Type: news

Selection tool accurately predicts ovarian damage in girls with cancer
(European Society of Human Reproduction and Embryology) Cancer treatments can cause premature ovarian failure (POI) including in girls who want to become mothers eventually. Ovarian tissue cryopreservation (OTC) provides a future fertility option but is invasive, has risks and evidence indicates that most girls don't develop POI. So, doctors face the dilemma of how to offer OTC appropriately. An assessment tool has been found to help predict correctly which female cancer patients aged under 18 years will develop POI and should therefore be offered OTC. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 29, 2021 Category: International Medicine & Public Health Source Type: news

A step forward for IVF patients with predicted poor response to treatment
(European Society of Human Reproduction and Embryology) Fertility patients who have a poor response to ovarian stimulation represent a stubborn challenge in IVF. Clinical guidelines indicate that increasing the drug dose for stimulation or applying any of several adjunct therapies are of little benefit. A study assessing two cycles of ovarian stimulation and two egg collections in the same menstrual cycle may yet provide a real advance for predicted poor responders in IVF. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 29, 2021 Category: International Medicine & Public Health Source Type: news

Oncotarget: Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
(Impact Journals LLC) Support recently reported findings of clinical benefit when relacorilant is added to paclitaxel-containing therapy in patients with ovarian and pancreatic cancers and provide a new rationale for combining relacorilant with additional cytotoxic agents. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news

Previous infection with COVID-19 does not affect the chance of success in IVF
(European Society of Human Reproduction and Embryology) More than a year after COVID-19 infection rates first hit peak levels and in the knowledge that receptors for SARS-CoV-2 are present in the ovary, are we able to assess the effect of the virus on reproductive function. A new study has shown that the ovarian reserve of women previously infected with the virus was not adversely affected, and that their chance of success from fertility treatment remained as it was before infection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2021 Category: International Medicine & Public Health Source Type: news

Researchers hope a protein blueprint might aid infertility treatments
(University of Cincinnati) University of Cincinnati researchers have developed a blueprint of the protein anti-M ü llerian hormone hormone helps form male reproductive organs and in females regulates follicle development and ovulation in the ovaries. That knowledge could help researchers treating female infertility. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 22, 2021 Category: International Medicine & Public Health Source Type: news

Fertility drugs used in IVF do NOT increase the risk of women developing breast cancer, study finds
There was no significant increase in the risk of breast cancer among women treated with any ovarian stimulation drug for infertility, say King's College London scientists. (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2021 Category: Consumer Health News Source Type: news

ESMO Gynaecological Cancers Virtual Congress 2021
(European Society for Medical Oncology) The first edition of the ESMO Gynaecological Cancers Congress will be held as a virtual meeting on 25-26 June 2021 and will focus on ovarian cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news

Ovarian Masses and O-RADS Ovarian Masses and O-RADS
This review describes a stepwise approach to evaluating and characterizing adnexal masses in non-pregnant patients utilizing ultrasound and the O-RADS classification system.Applied Radiology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - June 15, 2021 Category: Radiology Tags: Radiology Journal Article Source Type: news

CNN's Amanpour Being Treated for Ovarian Cancer CNN's Amanpour Being Treated for Ovarian Cancer
Christiane Amanpour, the chief international anchor for CNN, announced Monday at the start of her daily TV program that she's been diagnosed with ovarian cancer.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Health Highlights: June 15, 2021
Christiane Amanpour Reveals Ovarian Cancer Diagnosis After revealing that she's been diagnosed with ovarian cancer, CNN's chief international anchor Christiane Amanpour urged women to learn about and get regular cancer screenings. " I've had... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 15, 2021 Category: General Medicine Source Type: news

Model suggests surgery should precede chemotherapy for select patients with ovarian cancer
(NYU Langone Health / NYU Grossman School of Medicine) Certain patients with an aggressive form of ovarian cancer have a better chance of a cure through surgical removal of their tumor before chemotherapy instead of the reverse, a new study shows. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news

Researchers tout ovarian cancer alpha therapy at SNMMI 2021
New research in mice presented June 11 at the Society of Nuclear Medicine an...Read more on AuntMinnie.comRelated Reading: Niowave starts isotope production Niowave begins Mo-99 production in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 11, 2021 Category: Radiology Source Type: news

FDA approves niraparib for first-line maintenance of advanced ovarian cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancers
Hematology / Oncology Drug Approvals (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How Long Live After Diagnosed with Ovarian Cancer
How Long Do You Live After Being Diagnosed with Ovarian Cancer? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 11, 2021 Category: General Medicine Source Type: news

Promising ovarian cancer treatment proves effective and efficient
(Society of Nuclear Medicine and Molecular Imaging) Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant to traditional therapies, the new radiopharmaceutical can be produced in 25 minutes at low cost, which leads to better efficiency compared with alternative methods. This research was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2021 Category: International Medicine & Public Health Source Type: news

Oncotarget: Anti-hormonal treatment eligibility in granulosa cell tumors of the ovary
(Impact Journals LLC) Granulosa cell tumors are a well-defined ovarian cancer subtype, responsible for 2-5% of ovarian malignancies with an annual incidence of 0.6-1.0 per 100.000 women worldwide. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2021 Category: Cancer & Oncology Source Type: news

Drug Boosts Survival for Women With Advanced Ovarian Cancer
A recent study suggests that "maintenance therapy" with a targeted cancer drug may add years to some patients' lives. (Source: WebMD Health)
Source: WebMD Health - June 7, 2021 Category: Consumer Health News Source Type: news

Supreme Court rejects Johnson Johnson appeal challenging $2 billion talc verdict
(Natural News) The United States Supreme Court declined Tuesday, June 1, to take up an appeal by healthcare firm Johnson & Johnson that challenged a 2018 court ruling in favor of women who said they developed ovarian cancer from using some of the firm’s talcum powder products, leaving the verdict against the pharmaceutical giant intact.... (Source: NaturalNews.com)
Source: NaturalNews.com - June 7, 2021 Category: Consumer Health News Source Type: news

What Is Usually the First Sign of Ovarian Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

Horrifying study reveals mRNA vaccine nanoparticles are circulated throughout the entire body: Brain, heart, liver, ovaries, testes and more
(Natural News) Not surprisingly, everything the establishment tells us about covid vaccines has been a calculated lie. One of the biggest and most treacherous lies is that “mRNA vaccine shots stay in the arm and don’t circulate nanoparticles around the body.” Now we know that is a complete lie, as new research conducted in Japan... (Source: NaturalNews.com)
Source: NaturalNews.com - June 2, 2021 Category: Consumer Health News Source Type: news

J & J's Appeal Rejected by U.S. Supreme Court
The U.S. Supreme court said Tuesday that it won't hear Johnson & Johnson's appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company's talc products. (Source: WebMD Health)
Source: WebMD Health - June 2, 2021 Category: Consumer Health News Source Type: news

J & J's Appeal in $2 Billion Verdict Rejected by U.S. Supreme Court
WEDNESDAY, June 2, 2021 -- The U.S. Supreme Court said Tuesday that it will not hear Johnson& Johnson's appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company's talc products. The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 2, 2021 Category: Pharmaceuticals Source Type: news

U.S. Supreme Court Rejects J & J Appeal of $2 Billion Talc Verdict
The U.S. Supreme Court rejected a request June 1 from Johnson & Johnson to consider overturning a $2.1 billion award to 22 women who blamed the company’s asbestos-contaminated talcum powder products for causing ovarian cancer. With the Supreme Court declining to consider it, a Missouri state court ruling from 2018 that originally awarded $4.69 billion remains in place. A Missouri court of appeals reduced the award in 2020 to $2.1 billion, but also rejected a J&J effort to dismiss the jury verdict. The appeal did not involve the question of whether the products caused cancer. Johnson & Johnson wanted...
Source: Asbestos and Mesothelioma News - June 2, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

U.S. Supreme Court refuses to hear Johnson & Johnson appeal of $2B St. Louis baby powder verdict
Johnson& Johnson's had asked the high court to review a $2.1 billion award won by a group of women who said the company's baby powder caused their ovarian cancer. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 1, 2021 Category: Health Management Authors: Greg Edwards Source Type: news

Justices Reject Johnson & Johnson Appeal of $2B Talc Verdict Justices Reject Johnson & Johnson Appeal of $2B Talc Verdict
The Supreme Court is leaving in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using Johnson& Johnson talc products.Associated Press (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 1, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Justices reject Johnson & Johnson appeal of $2B talc verdict
The Supreme Court is leaving in place a $2 billion verdict in favor of women who say they developed ovarian cancer from using Johnson & Johnson talc products (Source: ABC News: Health)
Source: ABC News: Health - June 1, 2021 Category: Consumer Health News Tags: Health Source Type: news

'Electronic nose' accurately sniffs out hard-to-detect cancers
(University of Pennsylvania School of Medicine) An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95% accuracy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2021 Category: Cancer & Oncology Source Type: news

Ovarian cancer patients rushed on big decisions, cancer charities say
A THIRD of women with advanced ovarian cancer feel they are not given enough time to discuss important life and treatment choices, cancer charities say. (Source: Daily Express - Health)
Source: Daily Express - Health - May 31, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson asks high court to void $2B talc verdict
Johnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the company’s talc products (Source: ABC News: Health)
Source: ABC News: Health - May 31, 2021 Category: Consumer Health News Tags: Health Source Type: news

VC firm seeking $50M to invest in women ’s health technology
A new venture capital firm formed to invest in women ’s health technology is seeking to raise $50 million for its funding pool. The company, FemHealth Ventures, said it plans to make 15 investments from the fund. Maneesha Ghiya and partner Noraan Sadik formed Short Hills, New Jersey-based FemHealth Ventures in August of 2020 to fund companies tar geting treatments and cures for conditions appearing only in women, like endometriosis, polycystic ovarian syndrome and cervical cancer; mostly in women,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 30, 2021 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

VC firm seeking $50M to invest in women ’s health technology
A new venture capital firm formed to invest in women ’s health technology is seeking to raise $50 million for its funding pool. The company, FemHealth Ventures, said it plans to make 15 investments from the fund. Maneesha Ghiya and partner Noraan Sadik formed Short Hills, New Jersey-based FemHealth Ventures in August of 2020 to fund companies tar geting treatments and cures for conditions appearing only in women, like endometriosis, polycystic ovarian syndrome and cervical cancer; mostly in women,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 30, 2021 Category: Biotechnology Authors: Anne Stych Source Type: news

What People With Ovarian Cancer Wish You Knew
Here’s what people with ovarian cancer want you to know about this condition. (Source: WebMD Health)
Source: WebMD Health - May 28, 2021 Category: Consumer Health News Source Type: news

Novel way by NUS scientists to predict chemotherapy resistance in ovarian cancer patients
(National University of Singapore) Researchers from the National University of Singapore have found a way to predict if ovarian cancer patients will be resistant to chemotherapy. By using " automated " microscopy, they identified a protein that indicates the resistance of ovarian cancer cells to platinum chemotherapy. This breakthrough could improve the survival rate of ovarian cancer patients, as other treatments may be administered early. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 26, 2021 Category: Cancer & Oncology Source Type: news

Living With Ovarian Cancer
Learning to live with ovarian cancer can feel overwhelming. But there are ways to ease the transition. (Source: WebMD Health)
Source: WebMD Health - May 25, 2021 Category: Consumer Health News Source Type: news

MD Anderson researchers present new findings in targeted and combination therapies at 2021 ASCO Annual Meeting
(University of Texas M. D. Anderson Cancer Center) Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with melanoma, breast cancer, HER2-positive tumors and ovarian cancer. The results of these studies, which will be presented at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, highlight new advances in drug therapy research to improve patient outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 24, 2021 Category: Cancer & Oncology Source Type: news

I had ovarian cancer, was single and living by myself. But going through treatment, I was never alone.
You don’t need a spouse or partner to take care of you in a crisis. What you need is people — and connection. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 23, 2021 Category: Consumer Health News Authors: Jennifer Garam Source Type: news